🔎 Trials Near Me

Home › Kati

Pag-aaral pangklinika para sa Kati na nagre-recruit sa U.S.

15 pag-aaral para sa Kati ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06751056

Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

Nagre-recruitPhase 3
28 Days – 12 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07482787

Cardamom and Topical Roseomonas in Atopic Dermatitis

Nagre-recruitPhase 2
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT06096857

TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06748404

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT07219615

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

Nagre-recruitMaagang Phase 1
6 Months · Lahat ng kasarian · Na-update May 1, 2026 · NCT05649098

VR-PMR for Post-Burn Symptoms

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT07317271

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 24, 2025 · NCT06699121

Novel Strategies for Reducing Burn Scar Itch

Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 24, 2025 · NCT06801626

Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic

Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 19, 2025 · NCT06226610

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.